---
title: www.regeneron.com
description: www.regeneron.com Website IPv6 compatibility
published: true
date: 2024-02-06T14:26:42.351Z
tags: rank1, website
editor: markdown
dateCreated: 2024-02-05T20:04:07.507Z
---

# www.regeneron.com Website IPv6 compatibility

> The results shown here are accumulated by automation. If you're convinced the displayed data is wrong, please [contact the administrators](/howto/chat). 
{.is-info}

Regeneron Pharmaceuticals is a biotech company, known for its innovative treatments in areas like eye diseases, infectious diseases, and cancer. They prioritize research and development.


|   |   |
| - | - |
| Domainname | www.regeneron.com
| Category | pharmaceutical |
| IPv6 ranking | perfect :1st_place_medal: [ðŸ”—](/howto/ranking) |
| Explanation | The domain has an AAAA record, responds to ping, http and https. |
| Amount of AAAA records for domain | 3 |
| ICMPv6 success rate | 100.0%|
| HTTP success rate | 100.0% |
| HTTPS success rate | 100.0% |
| Last Check Timestamp | 2024-02-06 13:48:37+01:00 |

To see how this test was performed, please have a look at [our website test criteria howto](/howto/testcriteria/website)!


## What is www.regeneron.com about?
Regeneron Pharmaceuticals, Inc. is a biotechnology company known for its commitment to science-led innovation in the healthcare industry. The company's official website, www.regeneron.com, serves as a central platform for communicating its mission, showcasing its research initiatives, product information, and the latest developments in its various therapeutic areas.

The website provides an overview of Regeneron's leading-edge approach to developing and commercializing medicines for serious medical conditions. It emphasizes their proprietary technologies, such as the VelociSuiteÂ® platforms, which expedite the drug discovery process. Visitors can learn about Regeneron's marketed products, which target diseases such as eye diseases, cardiovascular disease, allergic and inflammatory diseases, cancer, and infectious diseases such as COVID-19.

Additionally, www.regeneron.com is a resource hub for patients, healthcare professionals, investors, and media, offering access to clinical trial data, investor relations information, company news, and career opportunities. It reflects the company's dedication to addressing unmet medical needs and improving lives through scientific discovery and innovation. Regeneron maintains a strong presence in the biopharmaceutical industry and its website illustrates its role as a leader in medical biotechnology.



<details>
<summary>Associated IP addresses</summary>

2606:4700:10::6816:229

2606:4700:10::ac43:1e03

2606:4700:10::6816:329

</details>
